BAD and neoplasm: GSEA of Biocarta pathways identified five up-regulated pathways with FDR < 0.05 in the M3 iSubtype, which were mainly involved in immune system (CTLA4, CSK, TCR) and tumor progression (SPPA, BAD) (Supplementary Table S2).